Weil Company’s iShares Biotechnology ETF IBB Stock Holding History

Weil Company’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,606	Closed	-$205K	–	116
2025 Q1	$205K	Sell	1,606 -673	-30%	-$91.3K	0.06%	102
2024 Q4	$301K	Hold	2,279	–	–	0.1%	94
2024 Q3	$332K	Hold	2,279	–	–	0.11%	121
2024 Q2	$313K	Hold	2,279	–	–	0.11%	121
2024 Q1	$313K	Hold	2,279	–	–	0.12%	121
2023 Q4	$310K	Buy	+2,279	New	+$278K	0.14%	106
2020 Q2	–	Sell	-4,525	Closed	-$488K	–	101
2020 Q1	$488K	Sell	4,525 -955	-17%	-$110K	0.46%	49
2019 Q4	$660K	Buy	5,480 +270	+5%	+$30.1K	0.5%	42
2019 Q3	$518K	Sell	5,210 -100	-2%	-$10.5K	0.38%	51
2019 Q2	$579K	Buy	5,310 +40	+0.8%	+$4.25K	0.47%	46
2019 Q1	$589K	Hold	5,270	–	–	0.49%	50
2018 Q4	$508K	Buy	+5,270	New	+$559K	0.46%	47

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return

Weil Company's IBB Position: Q2 2025 in Review

Weil Company sold out of iShares Biotechnology ETF (IBB) in Q2 2025, closing a stake of 1,606 shares — an estimated $205K sold.

Weil Company first reported a position in IBB in Q4 2018 and held it in 12 quarters. The position peaked at $660K in Q4 2019. 797 funds tracked by Wall St. Rank hold IBB as of Q2 2025.

Weil Company reported no remaining iShares Biotechnology ETF position as of Q2 2025 after selling out during the quarter.
Weil Company sold 1,606 iShares Biotechnology ETF shares in Q2 2025, an estimated $205K.
Weil Company first reported a position in iShares Biotechnology ETF in Q4 2018 and held it in 12 quarters.
Weil Company's iShares Biotechnology ETF position peaked at $660K in Q4 2019.
797 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2025.

Based on Weil Company's 13F filing for Q2 2025, filed 7 Aug 2025.